SKI Market

Indian Indices

Nifty

22,302.50 0.00
(0.00%)

Sensex

73,466.39 -45.46
( -0.06%)

Bank Nifty

48,021.10 -264.25
( -0.55%)

Nifty IT

33,335.15 -137.85
( -0.41%)

Global Indices

Nasdaq

16,332.56 -16.69
(-0.10%)

Dow Jones

38,884.26 31.99
(0.08%)

Hang Seng

18,313.86 -165.51
(-0.90%)

Nikkei 225

38,202.37 -632.73
(-1.63%)

Forex

USD-INR

83.47 0.09
(0.11%)

EUR-INR

89.90 0.16
(0.18%)

GBP-INR

104.87 0.26
(0.25%)

JPY-INR

0.54 0.00
(-0.42%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ishita Drugs & Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524400

INE806D01016

31.8401338

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

31.63

20.42

EPS(TTM)

Face Value()

Div & Yield %

2.16

Back

Ishita Drugs & Industries Ltd

Ishita Drugs & Industries standalone net profit rises 75.00% in the September 2023 quarter

Nov 09,2023

Net profit of Ishita Drugs & Industries rose 75.00% to Rs 0.21 crore in the quarter ended September 2023 as against Rs 0.12 crore during the previous quarter ended September 2022. Sales rose 54.93% to Rs 4.40 crore in the quarter ended September 2023 as against Rs 2.84 crore during the previous quarter ended September 2022.

Particulars	Quarter Ended
	Sep. 2023	Sep. 2022	% Var.
Sales	4.40	2.84	55
OPM %	4.77	4.93	-
PBDT	0.30	0.19	58
PBT	0.27	0.16	69
NP	0.21	0.12	75

22,302.50 0.00 (0.00%)

73,466.39 -45.46 ( -0.06%)

48,021.10 -264.25 ( -0.55%)

33,335.15 -137.85 ( -0.41%)

16,332.56 -16.69 (-0.10%)

38,884.26 31.99 (0.08%)

18,313.86 -165.51 (-0.90%)

38,202.37 -632.73 (-1.63%)

83.47 0.09 (0.11%)

89.90 0.16 (0.18%)

104.87 0.26 (0.25%)

0.54 0.00 (-0.42%)